PubMed Health treatment related to Tetralogy of Fallot: 63
Tetralogy of Fallot is repaired with open-heart surgery , either soon after birth or later in infancy. The goal of surgery is to repair the four defects of tetralogy of Fallot so the heart can work as normally as possible. Repairing the defects can greatly improve a child's health and quality of life. The pediatric cardiologist and cardiac surgeon will decide the best time to do the surgery . They will base their decision on your baby's health and weight and the severity of the defects and symptoms. Some teenagers or adults who had tetralogy of Fallot repaired in childhood need additional surgery to correct heart problems that develop over time. For more information, go to "Living With Tetralogy of Fallot."
Drugs for Tetralogy of Fallot (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 55)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Eplerenone |
Approved |
Phase 4 |
|
107724-20-9 |
443872 |
Synonyms:
9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone
Eplerenon
Eplerenona
EPLERENONE
Epoxymexrenone
|
Inspra
Inspra®|SC-66110
SC-66110
SC-6611O
|
|
2 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
3 |
|
diuretics |
|
Phase 4 |
|
|
|
4 |
|
Hormones |
|
Phase 4 |
|
|
|
5 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
6 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
7 |
|
Mineralocorticoids |
|
Phase 4 |
|
|
|
8 |
|
Mineralocorticoid Receptor Antagonists |
|
Phase 4 |
|
|
|
9 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 2, Phase 3 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
10 |
|
Dobutamine |
Approved |
Phase 3 |
|
34368-04-2 |
36811 |
Synonyms:
(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
(±)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-b-phenylethylamine
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-β-phenylethylamine
4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
Boehringer ingelheim brand OF dobutamine hydrochloride
COMPOUND 81929
COMPOUND-81929
DL-Dobutamine
Dobucor
Dobuject
Dobutamin
Dobutamin fresenius
Dobutamin hexal
Dobutamin ratiopharm
Dobutamin solvay
Dobutamina
Dobutamina [INN-Spanish]
Dobutamina inibsa
Dobutamina rovi
Dobutamine
Dobutamine (+)-isomer
Dobutamine [Usan:Ban:Inn]
Dobutamine [Usan]
Dobutamine Hcl
Dobutamine Hcl in Dextrose 5%
Dobutamine hydrobromide
Dobutamine hydrochloride
dobutamine hydrochloride|Dobutrex®|Inotrex®
Dobutamine lactobionate
Dobutamine phosphate (1:1) salt, (-)-isomer
|
Dobutamine tartrate
Dobutamine tartrate (1:1), (R-(r*,r*))-isomer
Dobutamine tartrate (1:1), (S-(r*,r*))-isomer
Dobutamine, (-)-isomer
Dobutamine, phosphate (1:1) salt (+)-isomer
Dobutamin-ratiopharm
Dobutaminum
Dobutaminum [INN-Latin]
Dobutrex
Eli lilly brand OF dobutamine hydrochloride
Fresenius brand OF dobutamine hydrochloride
Hexal brand OF dobutamine hydrochloride
Hydrobromide, dobutamine
Hydrochloride, dobutamine
Inibsa brand OF dobutamine hydrochloride
Inotrex
Irisfarma brand OF dobutamine hydrochloride
Juste brand OF dobutamine hydrochloride
Kendrick brand OF dobutamine hydrochloride
Lactobionate, dobutamine
Lilly 81929
Lilly brand OF dobutamine hydrochloride
Oxiken
Pisa brand OF dobutamine hydrochloride
Posiject
rac-Dobutamine
Racemic-dobutamine
Ratiopharm brand OF dobutamine hydrochloride
Rovi brand OF dobutamine hydrochloride
Solvay brand OF dobutamine hydrochloride
Tartrate, dobutamine
|
|
11 |
|
Adrenergic alpha-Agonists |
|
Phase 2, Phase 3 |
|
|
|
12 |
|
Hypnotics and Sedatives |
|
Phase 2, Phase 3 |
|
|
|
13 |
|
Analgesics, Non-Narcotic |
|
Phase 2, Phase 3 |
|
|
|
14 |
|
Analgesics |
|
Phase 2, Phase 3 |
|
|
|
15 |
|
Neurotransmitter Agents |
|
Phase 3 |
|
|
|
16 |
|
Adrenergic Agonists |
|
Phase 3 |
|
|
|
17 |
|
Adrenergic Agents |
|
Phase 3 |
|
|
|
18 |
|
Cardiotonic Agents |
|
Phase 3 |
|
|
|
19 |
|
Adrenergic beta-Agonists |
|
Phase 3 |
|
|
|
20 |
|
Sympathomimetics |
|
Phase 3 |
|
|
|
21 |
|
Protective Agents |
|
Phase 3 |
|
|
|
22 |
|
Losartan |
Approved |
Phase 2 |
|
114798-26-4 |
3961 |
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[<sup>3</sup>H]-losartan
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
Cozaar
Cozaar®|DuP 753|MK-954
DuP 753
DUP 89
DuP-753
HGP1405
HGP-1405
|
Hyzaar
Lortaan
LOSARTAN
Losartan monopotassium salt
Losartan potassium
Losartic
MK-954
Monopotassium salt, losartan
Potassium, losartan
Salt, losartan monopotassium
|
|
23 |
|
Angiotensin II |
Approved, Investigational |
Phase 2 |
|
68521-88-0, 11128-99-7, 4474-91-3 |
172198 |
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
5 L Isoleucine angiotensin II
5-Isoleucine-angiotensin II
5-L-Isoleucine angiotensin II
5-L-Isoleucineangiotensin II
Ang II
ANG-(1-8)octapeptide
Angiotensin
Angiotensin 2
Angiotensin II
Angiotensin II (human)
Angiotensin II (mouse)
Angiotensin II, 5-L-isoleucine
Angiotensin-(1-8) octapeptide
Angiotonin
|
Asp-arg-val-tyr-ile-his-pro-phe
Delivert
Human angiotensin II
Hypertensin
II, 5-L-isoleucine angiotensin
Ile(5)-angiotensin II
Ile5-angiotensin II
Isoleucine(5)-angiotensin
Isoleucine(5)-angiotensin II
isoleucine5-angiotensin II
Isoleucyl(5)-angiotensin II
N-(1-(N-(N-(N-(N-(N(2)-L-a-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-alpha-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-Α-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
Valyl(5)-angiotensin II
|
|
24 |
|
Sodium citrate |
Approved, Investigational |
Phase 2 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
25 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 2 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
ABSTRAL
Abstral®|Actiq®|Durogesic®|Effentora®|MCN-JR-4263-49|R-4263|Sublimaze®
ACTIQ
AD 923
AD-923
BREAKYL
Cephalon brand OF fentanyl buccal oravescent
Duragesic
DURAGESIC-100
DURAGESIC-12
DURAGESIC-25
DURAGESIC-37
DURAGESIC-50
DURAGESIC-75
Durogesic
DUROGESIC DTRANS
EFFENTORA
FENCINO
FENTALIS RESERVOIR
Fentanest
Fentanil
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl CII
Fentanyl citrate
FENTANYL-100
FENTANYL-12
FENTANYL-25
FENTANYL-37
FENTANYL-50
FENTANYL-62
FENTANYL-75
FENTANYL-87
Fentanylum
|
Fentanylum [INN-Latin]
Fentora
IDS-NF-001
INNOVAR
IONSYS
Janssen pharmaceutica brand OF fentanyl
LEPTANAL
MATRIFEN
MCN-JR-4263-49
MEZOLAR MATRIX
MYLAFENT
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N02AB03
Nasalfent
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
OPIODUR
ORALET
OSMACH
OSMANIL
PECFENT
Pentanyl
Phentanyl
R 4263
R-4263
Rapinyl
RECIVIT
Sentonil
Sublimaze
Subsys
TILOFYL
Transmucosal oral fentanyl citrate
VICTANYL
YEMEX
|
|
26 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 2 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
27 |
|
Angiotensinogen |
|
Phase 2 |
|
|
16133225 |
Synonyms:
Hypertensinogen
Proangiotensin
Renin substrate
Renin substrate tetradecapeptide
|
Renin-substrate
Serpin a8
SERPINA8
Tetradecapeptide, renin substrate
|
|
28 |
|
Angiotensin Receptor Antagonists |
|
Phase 2 |
|
|
|
29 |
|
Angiotensin II Type 1 Receptor Blockers |
|
Phase 2 |
|
|
|
30 |
|
Giapreza |
|
Phase 2 |
|
|
|
31 |
|
Calcium, Dietary |
|
Phase 2 |
|
|
|
32 |
|
Anesthetics, Intravenous |
|
Phase 2 |
|
|
|
33 |
|
Anesthetics, General |
|
Phase 2 |
|
|
|
34 |
|
Anticoagulants |
|
Phase 2 |
|
|
|
35 |
|
Analgesics, Opioid |
|
Phase 2 |
|
|
|
36 |
|
Citrate |
|
Phase 2 |
|
|
|
37 |
|
Narcotics |
|
Phase 2 |
|
|
|
38 |
|
Chelating Agents |
|
Phase 2 |
|
|
|
39 |
|
Pharmaceutical Solutions |
|
Phase 2 |
|
|
|
40 |
|
Calcium |
Nutraceutical |
Phase 2 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
41 |
|
Propranolol |
Approved, Investigational |
Phase 1 |
|
318-98-9, 525-66-6 |
62882 4946 |
Synonyms:
(+-)-1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-NAPHTHYLOXY)-2-HYDROXY-3-ISOPROPYLAMINOPROPANE HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHOXY)-PROPAN-2-OL HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-ISOPROPYLAMINO-3-(1-NAPHTHOXY)-PROPAN-2-OL-HYDROCHLORIDE
Anaprilin
Anapriline
ANGILOL
APSOLOL
Avlocardyl
AY-64043
AY-64043-
BEDRANOL
BEDRANOL S.R.
Bedranol®|Hemangiol®|Inderal®|propranolol hydrochloride
Beprane
BERKOLOL
Betachron
Betadren
BETADUR CR
Betalong
Beta-Neg
BETA-PROGRANE MR
beta-Propranolol
Beta-Tablinen
Beta-Timelets
b-Propranolol
CARDINOL
Caridolol
Corpendol
Deralin
Dexpropranolol
Dl-Propranolol Hydrochloride
Dociton
DUPROMEX
Duranol
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HALF BETA-PROGRANE MR
HALF PROPANIX LA
HALF PROPATARD LA
HALF-BEPRANE CR
HALF-BETADUR CR
HALF-INDERAL LA
HEMANGEOL
Hydrochloride, propranolol
ICI-45520
Inderal
INDERAL LA
|
Inderide
INDERIDE-40/25
INDERIDE-80/25
Indobloc
INNOPRAN
INNOPRAN XL
Intermigran
Kemi S
LEDERPRONOL
LOPRANOL LA
Migrastat
NSC-91523
Obsidan
Obzidan
Oposim
Prano-Puren
PROBETA LA
Propanalol
Propanix
PROPANIX LA
PROPANIX-10
PROPANIX-160
PROPANIX-160 SR
PROPANIX-40
PROPANIX-80
Propanolol
PROPATARD LA
Prophylux
Propranalol
PROPRANOLOL
PROPRANOLOL HCL
Propranolol Hcl Intensol
Propranolol hydrochloride
PROPRANOLOL HYDROCHLORIDE INTENSOL
Propranololo
Propranololum
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
RAPRANOL SR
Rapynogen
Reducor
Reducor Line
Rexigen
SAGITTOL
Servanolol
SLO-BLOK
SLO-PRO
SLOPROLOL
Sumial
SYPROL
TESNOL
Β-propranolol
|
|
42 |
|
Anesthetics |
|
Phase 1 |
|
|
|
43 |
|
Anti-Arrhythmia Agents |
|
Phase 1 |
|
|
|
44 |
|
Adrenergic beta-Antagonists |
|
Phase 1 |
|
|
|
45 |
|
Adrenergic Antagonists |
|
Phase 1 |
|
|
|
46 |
|
Vasodilator Agents |
|
Phase 1 |
|
|
|
47 |
|
Parathyroid hormone |
Approved, Investigational |
|
|
9002-64-6 |
|
Synonyms:
ALX1-11
ALX-111
ALX-1-11
NPSP558
NPSP-558
Parathormone
Parathormone (human recombinant)
Parathyrin
PARATHYROID HORMONE
Parathyroid hormone (1-84) human recombinant
|
Parathyroid hormone (rDNA)
PAROIDIN
PREOTACT
PTH
PTH(1-84)
rhPTH
rhPTH(1-84)
rPTH
rPTH(1-84)
|
|
48 |
|
Benzocaine |
Approved, Investigational |
|
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
49 |
|
Tannic acid |
Approved |
|
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
50 |
|
Tryptophan |
Approved, Nutraceutical, Withdrawn |
Early Phase 1 |
|
73-22-3 |
6305 |
Synonyms:
(-)-Tryptophan
(2S)-2-Amino-3-(1H-indol-3-yl)propanoate
(2S)-2-Amino-3-(1H-indol-3-yl)propanoic acid
(L)-Tryptophan
(S)-1H-Indole-3-alanine
(S)-2-AMINO-3-(1H-INDOL-3-YL)PROPANOIC ACID
(S)-2-Amino-3-(3-indolyl)propionic acid
(S)-a-Amino-1H-indole-3-propanoate
(S)-a-Amino-1H-indole-3-propanoic acid
(S)-a-Amino-b-(3-indolyl)-propionate
(S)-a-Amino-b-(3-indolyl)-propionic acid
(S)-a-Amino-b-indolepropionate
(S)-a-Amino-b-indolepropionic acid
(S)-a-Aminoindole-3-propionate
(S)-a-Aminoindole-3-propionic acid
(S)-alpha-Amino-1H-indole-3-propanoate
(S)-alpha-Amino-1H-indole-3-propanoic acid
(S)-alpha-Amino-beta-(3-indolyl)-propionate
(S)-alpha-Amino-beta-(3-indolyl)-propionic acid
(S)-alpha-Amino-beta-indolepropionate
(S)-alpha-Amino-beta-indolepropionic acid
(S)-alpha-Aminoindole-3-propionate
(S)-alpha-Aminoindole-3-propionic acid
(S)-Tryptophan
(S)-Α-amino-1H-indole-3-propanoate
(S)-Α-amino-1H-indole-3-propanoic acid
(S)-Α-amino-β-(3-indolyl)-propionate
(S)-Α-amino-β-(3-indolyl)-propionic acid
1beta-3-Indolylalanine
1-beta-3-Indolylalanine
1H-Indole-3-alanine
2-Amino-3-indolylpropanoate
2-Amino-3-indolylpropanoic acid
3-(1H-indol-3-yl)-L-Alanine
3-indol-3-Ylalanine
Alpha'-amino-3-indolepropionic acid
alpha-Amino-beta-(3-indolyl)-propionic acid
alpha-Aminoindole-3-propionic acid
Alti-Tryptophan
Ardeydorm
Ardeypharm brand OF tryptophan
Ardeytropin
Esparma brand OF tryptophan
GPPE PDR SACH
H-TRP-OH
ICN brand OF tryptophan
Indole-3-alanine
|
Kalma
Kalma brand OF tryptophan
L Tryptophan
L Tryptophan ratiopharm
L-(-)-Tryptophan
L(-)-TRYPTOPHAN
L-(−)-TRYPTOPHAN
l-a-Aminoindole-3-propionic acid
L-alpha-Amino-3-indolepropionic acid
L-alpha-Aminoindole-3-propionic acid
L-b-3-Indolylalanine
L-beta-3-Indolylalanine
Levotryptophan
Lopac-T-0254
L-TRP
L-Tryptofan
L-TRYPTOPHAN
L-Tryptophane
L-Tryptophan-ratiopharm
Lyphan
L-Β-3-indolylalanine
Merck brand OF tryptophan
Naturruhe
Niddapharm brand OF tryptophan
NSC-13119
Optimax
OPTIMAX WV
Pacitron
Pharmascience brand OF tryptophan
PMS Tryptophan
PMS-Tryptophan
Ratio tryptophan
Ratiopharm brand OF tryptophan
Ratio-tryptophan
Sedanoct
Triptofano
Trofan
Trp
Tryptacin
Tryptan
Tryptophan
Tryptophan metabolism alterations
TRYPTOPHAN, L-
Tryptophane
Tryptophanum
Upsher-smith brand OF tryptophan
W
|
|
Interventional clinical trials:
(show top 50)
(show all 70)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
MYOCARDIAL PROTECTION AND CLINICAL OUTCOME IN PATIENTS UNDERGOING TETRALOGY OF FALLOT REPAIR: A RANDOMIZED STUDY OF TWO CARDIOPLEGIC TECHNIQUES |
Completed |
NCT02646254 |
Phase 4 |
|
2 |
Eplerenone to Prevent Myocardial Fibrosis in Congenital Heart Disease |
Terminated |
NCT01971593 |
Phase 4 |
Eplerenone |
3 |
Multi-center Trial of Percutaneous Pulmonary Valve Implantation Using Venus-P Valve for Patients With Severe Pulmonary Regurgitation and Native Right Ventricular Outflow Tract After Previous Surgical Repair |
Unknown status |
NCT02590679 |
Phase 2, Phase 3 |
|
4 |
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot |
Recruiting |
NCT05579964 |
Phase 2, Phase 3 |
Dexmedetomidine Hcl 100 Mcg/mL Inj;Placebo |
5 |
Cardiac Imaging Under Exercise Stress Test for Early Assessment of Right Ventricular Function in Patients With Tetralogy of Fallot and Pulmonary Regurgitation |
Terminated |
NCT00564993 |
Phase 3 |
Dobutamin |
6 |
Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System |
Unknown status |
NCT02010905 |
Phase 2 |
Losartan;Placebo |
7 |
Stress Response in Children Undergoing Cardiac Surgery: a Prospective Randomized Comparison Between Low Dose Fentanyl (LDF), Low Dose Fentanyl Plus Dexmedetomidine (LDF + Dex) and High Dose Fentanyl (HDF). |
Completed |
NCT00848393 |
Phase 2 |
Fentanyl (High Dose);Fentanyl (Low Dose);Fentanyl (Low Dose) + Dexmedetomidine |
8 |
Contrast Enhanced Three Dimensional Echocardiographic Quantification of Right Ventricular Volumes in Repaired Congenital Heart Disease |
Recruiting |
NCT05186415 |
Phase 1, Phase 2 |
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] |
9 |
Optical Tissue Identification for Myocardial Architecture (OPTIMA Study) |
Active, not recruiting |
NCT04017975 |
Phase 2 |
Fluorescite |
10 |
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics |
Completed |
NCT01915277 |
Phase 1 |
Dexmedetomidine |
11 |
The Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Neonates Following Open Heart Surgery |
Completed |
NCT00576381 |
Phase 1 |
Dexmedetomidine |
12 |
The Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics of Dexmedetomidine In Infants Post-Operative From Cardiac Surgery |
Completed |
NCT00573066 |
Phase 1 |
Dexmedetomidine |
13 |
Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetrology of Fallot |
Not yet recruiting |
NCT04713657 |
Phase 1 |
Propranolol Hydrochloride;Placebo |
14 |
Cardiac 4D MR Velocity Mapping in Repaired Tetralogy of Fallot Patients: Evaluation of Pulmonary Regurgitant Fraction and Ventricular Volume |
Unknown status |
NCT02980614 |
|
|
15 |
Physical Capacity and Activity in Children With Congenital Heart Disease in Chile |
Unknown status |
NCT03275844 |
|
|
16 |
Comparison of Mid-term Results of Total Correction of Tetralogy of Fallot Between Preservation of Pulmonary Valve and Trans-annular Patching |
Unknown status |
NCT03732742 |
|
|
17 |
The Effect of Different Contouring Techniques on Cardiac Magnetic Resonance Assessment of Right Ventricular Volumes in Repaired Tetraology of Fallot: Implications on Preoperative Thresholds for Intervention |
Unknown status |
NCT04359940 |
|
|
18 |
Application of Biocardiac Model in Total Correction of Tetralogy of Fallot |
Unknown status |
NCT00155428 |
|
|
19 |
Imaging by 4 DFlow in Patients With Tetralogy of Fallot |
Unknown status |
NCT03542968 |
|
|
20 |
Reoxygenation Cardiopulmonary Bypass for Surgical Repair of Pediatric Cyanotic CHD |
Unknown status |
NCT03568357 |
|
|
21 |
Comparison of Right Ventricular Outflow Tract Gradient Under Anaesthesia With Post-operative Gradient in Patients Undergoing Tetralogy of Fallot Repair |
Unknown status |
NCT03234582 |
|
|
22 |
Haemodynamics and Function of the Atria in Patients With Congenital Heart Defects - Pilot Study by Cardiovascular Magnetic Resonance |
Unknown status |
NCT02161471 |
|
|
23 |
Right and Left Ventricle Remodeling Predictors After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot. |
Unknown status |
NCT02186691 |
|
|
24 |
Evaluation of Right Ventricular Contractility Reserve Function During Dobutamine Stress in Patients Following Surgical Repair of Tetralogy of Fallot |
Completed |
NCT00557934 |
|
|
25 |
Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot: Prospective Analysis of Myocardial Benefit Using Cardiac MRI and Echocardiography |
Completed |
NCT00536432 |
|
|
26 |
MRI Assessment of Right and Left Ventricular Strain, Associated Function, Volume and ECG Parameters as Predictors of Optimal Timing for Pulmonary Valve Replacement in Patients Post Repair for Tetralogy of Fallot |
Completed |
NCT00489788 |
|
|
27 |
Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot |
Completed |
NCT01941576 |
|
recombinant human brain natriuretic peptide (rhBNP);Placebo (0.9% sodium chloride) |
28 |
Tissue Doppler Imaging - A Promising Technique To Assess Myocardial Function In Adult Fallot Patients |
Completed |
NCT03835494 |
|
|
29 |
Effects of Changes in Fluid Status on Right Ventricular Volumes and Function |
Completed |
NCT02967315 |
|
|
30 |
Quantification of the Myocardial Microcirculation by Contrast Echocardiography In Adult Patients With Congenital Heart Disease |
Completed |
NCT00412685 |
|
|
31 |
Influence of Different Types of Exercise Training on Selected Cardiovascular Parameters in Adult Individuals With Corrected Tetralogy of Fallot |
Completed |
NCT02643810 |
|
|
32 |
Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation |
Completed |
NCT02586740 |
|
|
33 |
MRI Assessment of Right Ventricular Function in Patients After Repair of Tetralogy of Fallot |
Completed |
NCT00722826 |
|
|
34 |
Randomized Trial of Pulmonary Valve Replacement in Tetralogy of Fallot |
Completed |
NCT00112320 |
|
|
35 |
Early Revalvulation After Fallot Repair Improves Clinical Outcome |
Completed |
NCT02534792 |
|
|
36 |
Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects |
Completed |
NCT00004361 |
|
calcium gluconate;sodium citrate |
37 |
Non-invasive Imaging and Exercise Tolerance Tests in Post-repair Tetralogy of Fallot - Intervention and Course in Patients Over 8 Years Old |
Completed |
NCT00266188 |
|
|
38 |
Reproduction and Survival After Cardiac Defect Repair |
Completed |
NCT00005190 |
|
|
39 |
Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Tetralogy of Fallott Following Repair; A Comparison Study to cMRI |
Completed |
NCT01419756 |
|
|
40 |
Femoral Allogenic Vein Valved Conduit for Palliative Repair of Pulmonary Atresia With Ventricular Septal Defect |
Completed |
NCT02861963 |
|
|
41 |
Native Outflow Tract Transcatheter Pulmonary Valve Research Clinical Study |
Completed |
NCT01762124 |
|
|
42 |
Pulmonary Artery Repair With Covered Stents |
Completed |
NCT01824160 |
|
|
43 |
Interstitial Myocardial Fibrosis in Repaired Tetralogy of Fallot: Assessment by Molecular and Imaging Biomarkers and Association With Adverse Events ( Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study) |
Recruiting |
NCT04737135 |
|
|
44 |
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease |
Recruiting |
NCT04581668 |
|
|
45 |
Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation - Combined Cross-sectional and Prospective, Multi-centre, Randomized, Parallel-group Clinical Trial |
Recruiting |
NCT04084132 |
|
|
46 |
The International Stress Echo Study in Ischemic and Non-ischemic Heart Disease |
Recruiting |
NCT03049995 |
|
|
47 |
Do Cerebral and Renal Saturations Measured With Near-infrared Spectroscopy Correlate With Echocardiographic Markers of Perfusion and Cardiac Performance in Congenital Heart Disease? |
Recruiting |
NCT04106479 |
|
|
48 |
French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator |
Recruiting |
NCT03837574 |
|
|
49 |
Prospective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot |
Recruiting |
NCT04205461 |
|
|
50 |
Multicenter Italian Registry From the Italian Pediatric Cardiology Society (SICP) Working Group (WG) on CMR/CT for the Repaired Tetralogy of Fallot |
Recruiting |
NCT05288894 |
|
|
|